awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q40386800-03E6A3C0-EC40-4334-AA13-469E9AE8F072
Q40386800-03E6A3C0-EC40-4334-AA13-469E9AE8F072
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40386800-03E6A3C0-EC40-4334-AA13-469E9AE8F072
Phase 1 study of twice weekly pulse dose and daily low-dose erlotinib as initial treatment for patients with EGFR-mutant lung cancers.
P2860
Q40386800-03E6A3C0-EC40-4334-AA13-469E9AE8F072
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40386800-03E6A3C0-EC40-4334-AA13-469E9AE8F072
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4e52364e7b8b75097d23aad362870165068b645b
P2860
Erlotinib in previously treated non-small-cell lung cancer